Organ Preservation Solution Market Report 2025

The organ preservation solution market size has grown strongly in recent years. It will grow from $293.99 billion in 2024 to $316.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to a rise in organ transplants, growing awareness of organ donation, expansion of healthcare infrastructure, and increasing incidence of organ failure.

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $452.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising demand for extended criteria organs, expansion of organ procurement programs, focus on organ quality and functionality, and global initiatives to address organ shortage. Major trends in the forecast period include the application of preservation solutions in organ banking, market emphasis on extended preservation times, integration of additives for enhanced preservation, focus on portable and compact organ preservation devices, and collaborations for research and innovation in organ preservation.

The anticipated surge in organ transplantation is poised to drive the growth of the organ preservation solution market in the coming years. Organ transplantation, a surgical procedure involving the extraction and transfer of organs or tissues from a donor to a recipient, relies on organ preservation solutions to mitigate damage during transportation and storage, thereby enhancing organ viability for successful transplantation. For instance, data from the Organ Procurement and Transplantation Network (OPTN) in January 2023 revealed a 3.7 percent increase in organ transplants in 2022, totaling 42,887 procedures compared to 41,354 in 2021. Kidney transplants, constituting a significant share with 25,000 procedures, exhibited a 3.4 percent growth in the United States. Consequently, the upswing in organ transplantation is a key driver for the organ preservation solution market.

The growth of the organ preservation solution market is being propelled by rising healthcare spending. This term refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending employs organ preservation solutions to enhance the success rates of organ transplantation procedures. These solutions are essential for preserving organs during transportation and storage, ensuring their viability for transplantation. Investing in organ preservation solutions leads to improved outcomes for organ transplants, which in turn can reduce the need for additional transplantations and lower associated healthcare costs. For instance, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, which amounts to $8,740 per person. This represents a 2.8% increase compared to the previous year, which saw a growth rate of only 1.5% in 2022, highlighting a significant rebound in healthcare investment. Therefore, the increase in healthcare spending is driving the growth of the organ preservation solution market in the coming years.

Product innovation is a significant trend gaining traction in the organ preservation solution market. Leading companies in this sector are concentrating on developing cutting-edge products to enhance their position and secure a competitive edge. For example, in June 2024, Paragonix Technologies, a US-based firm specializing in organ preservation technology, introduced the PancreasPak Organ Preservation System. This device is the first to receive FDA clearance specifically designed to protect and monitor donor pancreases during transportation, underscoring its crucial role in organ transplantation. The system creates a controlled environment that maintains the pancreas at an optimal thermal range of 4-8°C, which is vital for preserving the organ's viability and functionality during transport, which can last up to 21 hours. The PancreasPak is also equipped with digital monitoring capabilities that continuously track the temperature and surrounding conditions of the pancreas. This real-time data facilitates immediate action in response to any deviations from optimal conditions, thereby enhancing organ preservation.

Moreover, major companies in the organ preservation solution market are actively pursuing technological advancements, particularly in the realm of organ tracking technology, as a strategic move to enhance their competitive standing in organ transportation. Organ tracking technology involves a spectrum of tools and systems dedicated to monitoring the location and condition of organs during transit. In October 2022, Paragonix Technologies Inc. unveiled its VantagePoint organ tracking technology, providing real-time tracking capabilities for donor organs in transit. This technology aims to enhance transparency and accountability in donor organ transportation, augmenting the digital tracking capabilities offered by the Paragonix App.

In September 2024, Getinge, a Sweden-based medical technology firm, acquired Paragonix Technologies for $253 million. This acquisition enables Getinge to enter the fast-growing organ preservation and transportation market, which is witnessing substantial growth driven by rising transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company specializing in organ preservation solutions.

Major companies operating in the organ preservation solution market include Bristol-Myers Squibb Company, Baxter International Inc., Accord Healthcare, BioLife Solutions Inc., Lifeline Scientific, TransMedics Group Inc., XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., OrganOx Limited, Shanghai Genext Pharmaceutical Technology, 21st Century Medicine, Institut Georges Lopez, Carnamedica, Global Transplant Solutions, Preservation Solutions Inc., Essential Pharmaceuticals LLC, Dr. Franz Köhler Chemie GmbH, Advanced Organ Preservation Solutions (OPSL Group), Vascular Perfusion Solutions Inc., Transplant Biomedicals SL.

North America was the largest region in the organ preservation solution market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.

There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.

The organ preservation solution research report is one of a series of new reports that provides organ preservation solution market statistics, including the organ preservation solution industry's global market size, regional shares, competitors with an organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.